HealthyDirect · GrowthFit for a long SIP
JM Small Cap Fund
JM Financial Mutual FundEquity Schemes - Small Cap Fund2.4 years
The Scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity related securities of small cap companies, as defined by SEBI.
- NAV
- 11.2853
- 29 Oct 2026
- 1Y
- +6.8%
- Trailing CAGR
- Upside capture
- +122%
- Vs NIFTY SMALLCAP 250 TRI
- Downside capture
- +101%
- Lower is better
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Buy checklist
History depth
Fail
2.4 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.98% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -24.4%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Deepak Gupta · 1.6 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 26.0% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 24%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+6.8%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+5.3%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+17.4%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +5.3%
- Calendar-day CAGR
- Excess 1Y
- +5.3%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Official benchmark
Date-aligned against NIFTY SMALLCAP 250 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
- 1Y excess
- +8.1%
- Fund minus TRI
- 3Y excess
- n/a
- Fund minus TRI
- Upside capture
- +122%
- Benchmark-up months
- Downside capture
- +101%
- Lower is better
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -24.4%
- Worst peak-to-trough
- Current
- -7.6%
- Below last peak
- Current spell
- 36 days
- Days below latest peak
- Time below peak
- +92%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 29 days
- 19 recovered episodes
- Longest recovery
- 471 days
- Trough to prior peak
24 Sept 2024 – 17 Jun 2026
Trough 3 Mar 2025 · recovered in 471 days
-24.4%
23 Sept 2026 – open
Trough 23 Oct 2026 · not recovered
-11.9%
30 Jul 2024 – 19 Aug 2024
Trough 6 Aug 2024 · recovered in 13 days
-5.9%
8 Sept 2026 – 23 Sept 2026
Trough 16 Sept 2026 · recovered in 7 days
-3.4%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
37
Vs category
83
Consistency
36
Risk-adjusted
29
Drawdown
39
Mean
45
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
No supporting reads in the current evidence set.
Portfolio
30 Sept 2026 · 90 holdings · top 10 are 26.0%.
- Top 5
- 15.6%
- Top 10
- 26.0%
- Largest holding
- 4.5%
- Effective holdings
- 63.5
Garware Hi-Tech Films Ltd
Materials
4.5%
Navin Fluorine International Ltd
Materials
3.0%
Ami Organics Ltd
Healthcare
2.9%
Five-Star Business Finance Ltd
Financial
2.7%
Shaily Engineering Plastics Ltd
Materials
2.5%
What changed
DECISION
Status moved from MONITOR to HEALTHY.
27 Oct 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Axis Small Cap Fund
Axis Mutual Fund
- 1Y
- +2.8%
- 3Y
- +14.0%
- Vol
- 14.7%
- Max DD
- -34.6%
- Sharpe
- 1.05
- 3Y win
- +71%
- Lower volatility
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Canara Robeco Small Cap Fund
Canara Robeco Mutual Fund
- 1Y
- -2.8%
- 3Y
- +10.7%
- Vol
- 17.6%
- Max DD
- -36.2%
- Sharpe
- 0.85
- 3Y win
- +61%
- Lower volatility
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Invesco India Small Cap Fund
Invesco Mutual Fund
- 1Y
- +6.9%
- 3Y
- +20.7%
- Vol
- 18.1%
- Max DD
- -37.7%
- Sharpe
- 0.92
- 3Y win
- +59%
- Lower volatility
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Mahindra Manulife Small Cap Fund
Mahindra Manulife Mutual Fund
- 1Y
- +8.2%
- 3Y
- +18.6%
- Vol
- 17.1%
- Max DD
- -26.0%
- Sharpe
- 1.00
- 3Y win
- +100%
- Lower volatility
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Mirae Asset Small Cap Fund
Mirae Asset Mutual Fund
- 1Y
- +1.3%
- 3Y
- n/a
- Vol
- 15.6%
- Max DD
- -15.1%
- Sharpe
- 0.40
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
Caveat: Lower trailing returns